Robert E Mayle, MD
Orthopedic Surgery · San Francisco
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 9
- 1 carrier
- Offices
- 2
Offices
2 locations · California Pacific Orthopaedics and Sports Medicine A Medical Corporat · Regents of the University of California - UCSF
Looking this up.
Hospitals listed: 057003 · 057004 · 057031 · 058189 · California Pacific Medical Center - Mission Bernal · California Pacific Medical Center- Van Ness Campus · California Pacific Medical Ctr-Davies Campus Hosp · Marinhealth Medical Center · Novato Community Hospital. That is not proof they admit you there this week.
Plans that list them
9 plans · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Mayle’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
California Medical Board record
Licence A98952 · Current
Licensed to practise in California · since 2007 · expires 2028-04-30 · Drexel University College of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
5 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- California Pacific Medical Center - Mission BernalSan Francisco, CAAcute Care Hospital · Voluntary non-profit - Church · Has an emergency departmentPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 3 of 5 · 76% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.322, Oct 2024 – Sep 2025
- California Pacific Medical Center- Van Ness CampusSan Francisco, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 4 of 5 · 78% would definitely recommend itOverall rating: 3 of 5 starsBetter than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.224, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.325, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.373, Oct 2024 – Sep 2025
- California Pacific Medical Ctr-Davies Campus HospSan Francisco, CAAcute Care Hospital · Voluntary non-profit - Other · No emergency departmentPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 3 of 5 · 74% would definitely recommend itOverall rating: 3 of 5 starsBetter than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.187, Oct 2024 – Sep 2025
- Marinhealth Medical CenterGreenbrae, CAAcute Care Hospital · Government - Hospital District or Authority · Has an emergency department · Birthing-friendlyPart of MarinHealthPatients rate it 3 of 5 · 76% would definitely recommend itOverall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.66 (3.59 to 7.73) · 1,505 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.177, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025
- Novato Community HospitalNovato, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 4 of 5 · 84% would definitely recommend itOverall rating: 5 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0, Oct 2024 – Sep 2025
See every measure and the patient survey for California Pacific Medical Center - Mission Bernal
Behind the star rating — Deaths: 0 better, 5 the same, 0 worse of 5 measures. Safety: 1 better, 6 the same, 0 worse of 7 measures. Readmissions: 0 better, 3 the same, 3 worse of 6 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0.322 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.24 (0.19 to 2.28) · 336 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.87 (0.47 to 1.27) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 163.19 (101.27 to 225.11) · 28 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 8.5 · 44 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9.6 · 155 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 13.4 · 177 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 11.6 · 32 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.2 · 1,281 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.19 (0 to 0.42) · 2,912 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.24 (0.04 to 0.45) · 2,681 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 4.07 (1.81 to 6.33) · 787 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.61 (0 to 3.31) · 425 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.46 (0.79 to 4.12) · 755 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 7.36 (0 to 16.38) · 431 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.47 (1.38 to 9.55) · 401 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.7 (0.2 to 3.2) · 105 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.27 (0 to 1.16) · 2,291 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 2.4 · 369 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.602 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 1.618 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0 | No different | Oct 2024 – Sep 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22 · 242 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 20.9 · 197 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 39.6 · 203 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.1 · 292 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 4.9 · 353 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.9 · 74 cases | None | Jul 2023 – Jun 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.7 to 1.4) · 110 cases | No different | Jan 2024 – Dec 2024 |
What patients said (406 patients answered, 18% of those asked)
| Cleanliness | 4 |
| Nurse communication | 3 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 3 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 4 |
| Room was "always" clean | 76% |
| Nurses "always" communicated well | 78% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 60% |
| Yes, staff "did" give patients this information | 86% |
| Yes, staff "did" give patients information about help after discharge | 85% |
| Doctors "always" explained things so they could understand | 78% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 86% |
| Patients who gave a rating of "9" or "10" (high) | 74% |
| Staff "always" explained new medications | 74% |
| Nurses "always" explained things so they could understand | 76% |
| Nurses "always" listened carefully | 75% |
| Nurses "always" treated them with courtesy and respect | 83% |
| "Always" quiet at night | 53% |
| "YES", patients would definitely recommend the hospital | 76% |
| Staff "always" explained possible side effects | 47% |
| Yes, staff "did" give patients information about possible symptoms | 87% |
See every measure and the patient survey for California Pacific Medical Center- Van Ness Campus
Behind the star rating — Deaths: 0 better, 8 the same, 0 worse of 8 measures. Safety: 1 better, 6 the same, 0 worse of 7 measures. Readmissions: 0 better, 8 the same, 2 worse of 10 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.224 | Better | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.325 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.373 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.14 (0.3 to 1.97) · 2,271 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.05 (0.81 to 1.28) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 192.86 (151.51 to 234.22) · 140 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.6 · 55 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 10.3 · 60 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10.5 · 143 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9.8 · 356 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 14.3 · 259 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.1 · 173 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.1 · 2,316 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.31 (0.12 to 0.49) · 6,430 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.09 to 0.47) · 7,168 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.3 (1.5 to 5.09) · 2,196 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 2.47 (1.21 to 3.74) · 925 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.63 (1.37 to 3.88) · 1,954 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 10.13 (6.06 to 14.2) · 1,112 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 7.26 (4.67 to 9.85) · 1,084 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.67 (0.31 to 3.03) · 832 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.33 (0 to 0.85) · 5,406 cases | No different | Jul 2022 – Jun 2024 |
| MRSA BacteremiaInfections | 0.443 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.717 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.3 · 200 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22.3 · 449 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 18.2 · 187 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 8.7 · 418 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 7.1 · 260 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 19.2 · 293 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.2 (3.6 to 7.6) · 157 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 10.2 (7.7 to 13.5) · 157 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission for CABGUnplanned return visits | 11 · 33 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.2 · 66 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.5 (9.4 to 16.7) · 551 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.7 to 1.3) · 219 cases | No different | Jan 2024 – Dec 2024 |
What patients said (478 patients answered, 20% of those asked)
| Cleanliness | 4 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 74% |
| Doctors "always" communicated well | 77% |
| Staff "always" explained | 59% |
| Yes, staff "did" give patients this information | 88% |
| Yes, staff "did" give patients information about help after discharge | 88% |
| Doctors "always" explained things so they could understand | 71% |
| Doctors "always" listened carefully | 75% |
| Doctors "always" treated them with courtesy and respect | 85% |
| Patients who gave a rating of "9" or "10" (high) | 75% |
| Staff "always" explained new medications | 75% |
| Nurses "always" explained things so they could understand | 70% |
| Nurses "always" listened carefully | 71% |
| Nurses "always" treated them with courtesy and respect | 82% |
| "Always" quiet at night | 53% |
| "YES", patients would definitely recommend the hospital | 78% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 88% |
See every measure and the patient survey for California Pacific Medical Ctr-Davies Campus Hosp
Behind the star rating — Deaths: 0 better, 4 the same, 0 worse of 4 measures. Safety: 1 better, 5 the same, 0 worse of 6 measures. Readmissions: 0 better, 4 the same, 1 worse of 5 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.187 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.02 (0 to 2.09) · 232 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.98 (0.56 to 1.4) | No different | Jul 2022 – Jun 2024 |
| Death rate for heart failure patientsComplications and deaths | 10 · 72 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 15.1 · 106 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.4 · 257 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.8 · 721 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.26 (0.03 to 0.49) · 2,031 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.25 (0.04 to 0.45) · 2,032 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.35 (0.94 to 5.76) · 419 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.41 (0 to 3) · 211 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.84 (1.24 to 4.44) · 414 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 11.95 (2.91 to 20.98) · 218 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.61 (1.47 to 9.75) · 198 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.74 (0.22 to 3.26) · 52 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.32 (0 to 1.28) · 1,461 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.6 · 58 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 1.756 | No different | Oct 2024 – Sep 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22.1 · 91 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 65.3 · 84 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -26.6 · 115 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.4 · 142 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.5 · 55 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.6 · 25 cases | None | Jul 2023 – Jun 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.7 to 1.3) · 312 cases | No different | Jan 2024 – Dec 2024 |
What patients said (602 patients answered, 22% of those asked)
| Cleanliness | 4 |
| Nurse communication | 2 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 3 |
| Overall hospital rating | 3 |
| Quietness | 2 |
| Recommend hospital | 4 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 73% |
| Doctors "always" communicated well | 79% |
| Staff "always" explained | 59% |
| Yes, staff "did" give patients this information | 86% |
| Yes, staff "did" give patients information about help after discharge | 88% |
| Doctors "always" explained things so they could understand | 73% |
| Doctors "always" listened carefully | 78% |
| Doctors "always" treated them with courtesy and respect | 85% |
| Patients who gave a rating of "9" or "10" (high) | 70% |
| Staff "always" explained new medications | 72% |
| Nurses "always" explained things so they could understand | 68% |
| Nurses "always" listened carefully | 71% |
| Nurses "always" treated them with courtesy and respect | 81% |
| "Always" quiet at night | 46% |
| "YES", patients would definitely recommend the hospital | 74% |
| Staff "always" explained possible side effects | 46% |
| Yes, staff "did" give patients information about possible symptoms | 85% |
See every measure and the patient survey for Marinhealth Medical Center
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 1 better, 6 the same, 0 worse of 7 measures. Readmissions: 3 better, 8 the same, 0 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 5.66 (3.59 to 7.73) · 1,505 cases | Worse | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.177 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.446 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.85 (0 to 1.83) · 1,056 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.04 (0.72 to 1.36) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 167.34 (112.58 to 222.09) · 57 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.9 · 47 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 8.5 · 119 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 9.6 · 257 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9.5 · 428 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 11.4 · 477 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.3 · 197 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.1 · 2,827 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.18 (0 to 0.38) · 6,990 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.21 (0.02 to 0.41) · 6,838 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.41 (0 to 3) · 664 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.86 (1.4 to 4.33) · 1,436 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 10.38 (3.68 to 17.08) · 705 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 4.38 (0.72 to 8.04) · 672 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.66 (0.18 to 3.15) · 300 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.56 (0 to 1.25) · 5,550 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.4 · 76 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.396 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 13.1 · 275 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22 · 427 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -20.3 · 289 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 3.3 · 494 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -4.9 · 499 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17.9 · 435 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.5 (3.6 to 8.4) · 93 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 11.2 (7.8 to 16) · 93 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.6 · 84 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.5 · 53 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.3 · 111 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13 (10.3 to 16.5) · 2,119 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.1 (0.8 to 1.4) · 670 cases | No different | Jan 2024 – Dec 2024 |
What patients said (1,233 patients answered, 19% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 2 |
| Discharge information | 3 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 4 |
| Room was "always" clean | 68% |
| Nurses "always" communicated well | 73% |
| Doctors "always" communicated well | 74% |
| Staff "always" explained | 56% |
| Yes, staff "did" give patients this information | 85% |
| Yes, staff "did" give patients information about help after discharge | 85% |
| Doctors "always" explained things so they could understand | 71% |
| Doctors "always" listened carefully | 72% |
| Doctors "always" treated them with courtesy and respect | 80% |
| Patients who gave a rating of "9" or "10" (high) | 72% |
| Staff "always" explained new medications | 70% |
| Nurses "always" explained things so they could understand | 68% |
| Nurses "always" listened carefully | 68% |
| Nurses "always" treated them with courtesy and respect | 82% |
| "Always" quiet at night | 48% |
| "YES", patients would definitely recommend the hospital | 76% |
| Staff "always" explained possible side effects | 43% |
| Yes, staff "did" give patients information about possible symptoms | 85% |
See every measure and the patient survey for Novato Community Hospital
Behind the star rating — Deaths: 0 better, 5 the same, 0 worse of 5 measures. Safety: 0 better, 3 the same, 0 worse of 3 measures. Readmissions: 0 better, 7 the same, 0 worse of 7 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1 (0 to 2.06) · 213 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.85 (0.4 to 1.3) | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 8.2 · 25 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 10 · 111 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 16.1 · 140 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 11.3 · 42 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.8 · 627 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.2 (0 to 0.43) · 1,872 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.25 (0.04 to 0.46) · 1,796 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 2.92 (0.5 to 5.33) · 505 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.64 (0 to 3.36) · 317 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.2 (0.51 to 3.88) · 495 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 7.93 (0 to 17.29) · 323 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 4.88 (0.69 to 9.07) · 311 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.75 (0.22 to 3.27) · 96 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.41 (0 to 1.49) · 1,320 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.2 · 143 cases | None | Apr 2023 – Mar 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.6 · 108 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -31.9 · 121 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 1.1 · 150 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.6 · 143 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.4 · 118 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.6 · 27 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.5 (9.5 to 16.5) · 930 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.7 to 1.3) · 184 cases | No different | Jan 2024 – Dec 2024 |
What patients said (334 patients answered, 30% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 5 |
| Room was "always" clean | 78% |
| Nurses "always" communicated well | 81% |
| Doctors "always" communicated well | 83% |
| Staff "always" explained | 63% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 89% |
| Doctors "always" explained things so they could understand | 78% |
| Doctors "always" listened carefully | 84% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 82% |
| Staff "always" explained new medications | 77% |
| Nurses "always" explained things so they could understand | 76% |
| Nurses "always" listened carefully | 82% |
| Nurses "always" treated them with courtesy and respect | 86% |
| "Always" quiet at night | 54% |
| "YES", patients would definitely recommend the hospital | 84% |
| Staff "always" explained possible side effects | 49% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
Original Medicare doctor bills
$664,409
Medicare paid this office $664,409 for 1,075 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Replacement of thigh bone and hip joint with prosthesis | 185 | $221,874 | $1,156 |
| Replacement of knee joint, both sides of knee | 118 | $139,214 | $1,160 |
| Return visit (30+ min) | 450 | $62,579 | $114 |
| Short return visit (20+ min) | 411 | $41,292 | $77 |
| X-ray of hip, 2-3 views | 389 | $22,073 | $45 |
See all 24 services
| Replacement of thigh bone and hip joint with prosthesis | 185 | $221,874 | $1,156 |
| Replacement of knee joint, both sides of knee | 118 | $139,214 | $1,160 |
| Return visit (30+ min) | 450 | $62,579 | $114 |
| Short return visit (20+ min) | 411 | $41,292 | $77 |
| X-ray of hip, 2-3 views | 389 | $22,073 | $45 |
| New patient visit (45+ min) | 104 | $15,104 | $145 |
| Computer-assisted surgery for muscle and bone procedure | 106 | $13,295 | $122 |
| X-ray of both knees while standing | 320 | $12,778 | $38 |
| Treatment of broken neck of thigh bone with bone implant | 11 | $12,270 | $1,115 |
| Computer-assisted, fluoroscopic image-guided musculoskeletal surgical navigational orthopedic operation | 137 | $11,936 | $83 |
| X-ray of knee, 1-2 views | 320 | $10,740 | $32 |
| Hyaluronan or derivative, durolane, for intra-articular injection, 1 mg | 25 | $10,635 | None |
| Aspiration and/or injection of fluid from large joint | 119 | $9,199 | $59 |
| New patient visit (30+ min) | 96 | $8,956 | $93 |
| Mri scan of leg joint without contrast | 54 | $8,676 | $145 |
| Hyaluronan or derivative, trivisc, for intra-articular injection, 1 mg | 14 | $5,976 | None |
| Long return visit (40+ min) | 20 | $3,419 | $171 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 24 | $2,759 | $115 |
| X-ray of both hips, 3-4 views | 32 | $1,496 | $47 |
| Injection, methylprednisolone acetate, 1 mg | 123 | $1,246 | None |
| Mri scan of lower spinal canal without contrast | 12 | $1,058 | $88 |
| Injection, methylprednisolone acetate, 40 mg | 84 | $840 | None |
| Aspiration and/or injection of fluid from medium joint | 14 | $505 | $36 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 43 | $147 | None |
Procedures Medicare counted
| Hip replacement | 194 | More than 99% of doctors who do this |
| Knee replacement | 158 | More than 98% of doctors who do this |
Who their Medicare patients are
1,075 Original Medicare patients in 2024. Average age 76 · Under 65 1% · 85 and older 8% · Women 64% · Also on Medicaid 5% · Health risk score 0.87. At or below the middle of the specialty; the typical orthopedic surgery clinician is at 1.13.
Conditions among them: High blood pressure 63% · Coronary heart disease 22% · Depression 18% · Cancer 16% · Atrial fibrillation 16% · Diabetes 15% · Chronic kidney disease 14% · Heart failure 8% · COPD 8% · Dementia 4% · Stroke 4%.
The office billed $2,704,661, Medicare allowed $861,932 and paid $664,409; for 19,203 services of 58 kinds; $18,959 of it was for drugs given in the office and $645,450 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 1,075 | 19,203 | 76 | 0.87 | $2,704,661 | $664,409 |
| 2023 | 1,006 | 6,706 | 75 | 0.88 | $2,421,088 | $614,622 |
| 2022 | 904 | 4,305 | 75 | 0.87 | $1,950,570 | $513,456 |
| 2021 | 800 | 3,620 | 75 | 0.95 | $1,694,385 | $449,527 |
| 2020 | 677 | 3,221 | 75 | 1.01 | $1,241,204 | $330,348 |
| 2019 | 784 | 3,566 | 75 | 1.08 | $1,300,929 | $397,054 |
| 2018 | 777 | 3,205 | 75 | 1.02 | $1,363,401 | $350,889 |
| 2017 | 739 | 3,088 | 74 | 1.06 | $1,356,096 | $332,881 |
| 2016 | 669 | 3,375 | 75 | 1.14 | $1,387,883 | $339,392 |
| 2015 | 537 | 2,732 | 75 | 1.15 | $1,231,122 | $297,999 |
| 2014 | 484 | 2,042 | 76 | 1.21 | $1,029,375 | $238,915 |
| 2013 | 453 | 1,924 | 74 | 1.21 | $820,596 | $194,895 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 26 services
| Replacement of thigh bone and hip joint with prosthesis | 161 | $191,720 | $1,155 |
| Replacement of knee joint, both sides of knee | 93 | $110,250 | $1,148 |
| Return visit (30+ min) | 372 | $52,457 | $115 |
| Short return visit (20+ min) | 438 | $48,915 | $79 |
| X-ray of hip, 2-3 views | 390 | $21,967 | $44 |
| New patient visit (45+ min) | 146 | $21,126 | $145 |
| Hyaluronan or derivative, trivisc, for intra-articular injection, 1 mg | 36 | $18,100 | None |
| Total hip replacement after previous hip surgery | 12 | $17,978 | $1,498 |
| New patient visit (30+ min) | 159 | $15,726 | $99 |
| Aspiration and/or injection of fluid from large joint | 182 | $14,798 | $61 |
| X-ray of both knees while standing | 303 | $12,059 | $38 |
| Computer-assisted, fluoroscopic image-guided musculoskeletal surgical navigational orthopedic operation | 108 | $9,285 | $84 |
| Computer-assisted surgery for muscle and bone procedure | 68 | $8,677 | $124 |
| X-ray of knee, 1-2 views | 249 | $8,419 | $32 |
| Long return visit (40+ min) | 33 | $5,043 | $153 |
| Mri scan of leg joint without contrast | 35 | $5,009 | $132 |
| Injection, methylprednisolone acetate, 40 mg | 208 | $3,411 | None |
| Aspiration and/or injection of fluid from medium joint | 39 | $2,050 | $48 |
| X-ray of both hips, 3-4 views | 31 | $1,679 | $54 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 14 | $1,611 | $115 |
| Telephone medical discussion with physician, 11-20 minutes | 16 | $1,234 | $73 |
| Short return visit | 11 | $653 | $50 |
| X-ray of lower and sacral spine, 2-3 views | 18 | $585 | $31 |
| Telephone medical discussion with physician, 5-10 minutes | 15 | $466 | $29 |
| X-ray of pelvis, 1-2 views | 16 | $446 | $26 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 11 | $39 | None |
2022: 26 services
| Replacement of thigh bone and hip joint with prosthesis | 112 | $133,559 | $1,151 |
| Replacement of knee joint, both sides of knee | 72 | $87,650 | $1,169 |
| Short return visit (20+ min) | 410 | $45,384 | $78 |
| Return visit (30+ min) | 306 | $42,627 | $114 |
| X-ray of hip, 2-3 views | 359 | $20,405 | $44 |
| Aspiration and/or injection of fluid from large joint | 207 | $19,595 | $62 |
| Long return visit (40+ min) | 96 | $15,133 | $153 |
| New patient visit (45+ min) | 98 | $14,737 | $150 |
| New patient visit (30+ min) | 149 | $14,367 | $96 |
| Mri scan of leg joint without contrast | 58 | $10,193 | $142 |
| Hyaluronan or derivative, euflexxa, for intra-articular injection, per dose | 25 | $7,880 | None |
| X-ray of knee, 3 views | 147 | $5,925 | $38 |
| New patient visit (60+ min) | 30 | $5,592 | $186 |
| Computer-assisted, fluoroscopic image-guided musculoskeletal surgical navigational orthopedic operation | 61 | $5,399 | $86 |
| Computer-assisted surgery for muscle and bone procedure | 41 | $5,176 | $126 |
| X-ray of both knees while standing | 96 | $3,930 | $40 |
| Injection, methylprednisolone acetate, 40 mg | 231 | $3,515 | None |
| X-ray of knee, 1-2 views | 58 | $2,185 | $35 |
| Aspiration and/or injection of fluid from medium joint | 37 | $1,967 | $48 |
| Telephone medical discussion with physician, 11-20 minutes | 27 | $1,638 | $56 |
| X-ray of lower and sacral spine, 2-3 views | 28 | $959 | $34 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 14 | $944 | $63 |
| Short return visit | 15 | $807 | $54 |
| X-ray of pelvis, 1-2 views | 22 | $626 | $26 |
| Telephone medical discussion with physician, 5-10 minutes | 13 | $312 | $24 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 18 | $102 | None |
2021: 23 services
| Replacement of thigh bone and hip joint with prosthesis | 116 | $141,501 | $1,169 |
| Replacement of knee joint, both sides of knee | 52 | $62,479 | $1,179 |
| Return visit (30+ min) | 281 | $39,944 | $116 |
| Short return visit (20+ min) | 336 | $38,386 | $79 |
| Aspiration and/or injection of fluid from large joint | 199 | $18,347 | $60 |
| X-ray of hip, 2-3 views | 311 | $15,791 | $42 |
| New patient visit (30+ min) | 146 | $14,132 | $97 |
| Long return visit (40+ min) | 69 | $12,397 | $168 |
| Mri scan of leg joint without contrast | 61 | $10,774 | $150 |
| New patient visit (45+ min) | 64 | $8,697 | $136 |
| X-ray of knee, 3 views | 188 | $7,505 | $37 |
| New patient visit (60+ min) | 35 | $7,145 | $204 |
| Hyaluronan or derivative, euflexxa, for intra-articular injection, per dose | 25 | $5,864 | None |
| Injection, methylprednisolone acetate, 40 mg | 222 | $3,153 | None |
| Aspiration and/or injection of fluid from medium joint | 35 | $2,034 | $44 |
| Mri scan of lower spinal canal without contrast | 15 | $1,757 | $117 |
| Telephone medical discussion with physician, 11-20 minutes | 26 | $1,536 | $59 |
| Computer-assisted, fluoroscopic image-guided musculoskeletal surgical navigational orthopedic operation | 17 | $1,480 | $87 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 22 | $1,410 | $64 |
| Telephone medical discussion with physician, 5-10 minutes | 30 | $951 | $30 |
| X-ray of both knees while standing | 24 | $849 | $35 |
| X-ray of pelvis, 1-2 views | 24 | $677 | $28 |
| X-ray of lower and sacral spine, 2-3 views | 17 | $638 | $38 |
2020: 24 services
| Replacement of thigh bone and hip joint with prosthesis | 81 | $102,467 | $1,235 |
| Replacement of knee joint, both sides of knee | 30 | $38,390 | $1,238 |
| Short return visit (20+ min) | 318 | $31,292 | $65 |
| Return visit (30+ min) | 234 | $25,532 | $93 |
| Aspiration and/or injection of fluid from large joint | 179 | $15,739 | $61 |
| New patient visit (30+ min) | 126 | $11,085 | $88 |
| X-ray of hip, 2-3 views | 170 | $8,317 | $43 |
| New patient visit (45+ min) | 57 | $8,239 | $145 |
| Hyaluronan or derivative, euflexxa, for intra-articular injection, per dose | 20 | $7,369 | None |
| Mri scan of leg joint without contrast | 43 | $7,143 | $152 |
| X-ray of knee, 3 views | 99 | $3,941 | $38 |
| X-ray of hip, 1 view | 109 | $3,746 | $28 |
| X-ray of both knees while standing | 100 | $3,707 | $36 |
| X-ray of knee, 1-2 views | 77 | $2,521 | $32 |
| Mri scan of lower spinal canal without contrast | 14 | $1,910 | $136 |
| Aspiration and/or injection of fluid from medium joint | 29 | $1,516 | $46 |
| Injection, methylprednisolone acetate, 40 mg | 121 | $1,419 | None |
| Injection, methylprednisolone acetate, 80 mg | 98 | $1,143 | None |
| Short return visit | 21 | $931 | $40 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 13 | $851 | $65 |
| X-ray of pelvis, minimum of 3 views | 13 | $538 | $41 |
| Telephone medical discussion with physician, 5-10 minutes | 13 | $434 | $31 |
| X-ray of pelvis, 1-2 views | 13 | $289 | $22 |
| X-ray of both hips, 2 views | 20 | $204 | $10 |
2019: 24 services
| Replacement of thigh bone and hip joint with prosthesis | 76 | $93,979 | $1,221 |
| Replacement of knee joint, both sides of knee | 39 | $51,839 | $1,234 |
| Short return visit (20+ min) | 429 | $38,495 | $63 |
| Return visit (30+ min) | 278 | $33,513 | $99 |
| Aspiration and/or injection of fluid from large joint | 219 | $18,619 | $58 |
| New patient visit (30+ min) | 144 | $13,291 | $92 |
| Mri scan of leg joint without contrast | 45 | $8,729 | $171 |
| X-ray of hip, 1 view | 202 | $8,406 | $29 |
| X-ray of both knees while standing | 185 | $7,162 | $36 |
| New patient visit (45+ min) | 45 | $6,636 | $147 |
| Hyaluronan or derivative, euflexxa, for intra-articular injection, per dose | 22 | $6,085 | None |
| X-ray of knee, 1-2 views | 170 | $5,868 | $31 |
| Injection, methylprednisolone acetate, 80 mg | 215 | $3,119 | None |
| X-ray of knee, 3 views | 65 | $2,808 | $36 |
| X-ray of pelvis, 1-2 views | 67 | $2,348 | $33 |
| X-ray of hip, 2-3 views | 53 | $2,185 | $40 |
| Aspiration and/or injection of fluid from medium joint | 44 | $2,067 | $44 |
| Mri scan of lower spinal canal without contrast | 12 | $1,634 | $136 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 24 | $1,558 | $65 |
| Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days | 12 | $1,278 | $67 |
| Short return visit | 34 | $1,136 | $33 |
| X-ray of lower and sacral spine, 2-3 views | 18 | $664 | $35 |
| X-ray of both hips, 2 views | 40 | $419 | $10 |
| Injection, methylprednisolone acetate, 40 mg | 17 | $104 | None |
2018: 23 services
| Replacement of thigh bone and hip joint with prosthesis | 67 | $83,807 | $1,197 |
| Replacement of knee joint, both sides of knee | 38 | $48,270 | $1,207 |
| Short return visit (20+ min) | 467 | $43,955 | $66 |
| Aspiration and/or injection of fluid from large joint | 235 | $19,863 | $59 |
| Return visit (30+ min) | 170 | $18,996 | $99 |
| Replacement of knee joint on side of knee | 15 | $15,920 | $1,061 |
| New patient visit (30+ min) | 165 | $15,372 | $93 |
| X-ray of both knees while standing | 193 | $8,448 | $36 |
| X-ray of knee, 1-2 views | 185 | $7,190 | $31 |
| X-ray of hip, 1 view | 173 | $7,158 | $30 |
| Hyaluronan or derivative, euflexxa, for intra-articular injection, per dose | 21 | $6,738 | None |
| New patient visit (45+ min) | 39 | $5,751 | $147 |
| Injection, methylprednisolone acetate, 80 mg | 215 | $3,393 | None |
| X-ray of hip, 2-3 views | 75 | $3,043 | $40 |
| Mri scan of leg joint without contrast | 16 | $2,714 | $170 |
| Aspiration and/or injection of fluid from medium joint | 45 | $2,303 | $45 |
| Short return visit | 37 | $1,460 | $38 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 19 | $1,222 | $64 |
| X-ray of knee, 3 views | 36 | $1,135 | $31 |
| X-ray of pelvis, 1-2 views | 34 | $1,118 | $32 |
| X-ray of lower and sacral spine, 2-3 views | 14 | $489 | $35 |
| Injection, methylprednisolone acetate, 40 mg | 33 | $203 | None |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 11 | $54 | None |
2017: 22 services
| Replacement of thigh bone and hip joint with prosthesis | 66 | $84,571 | $1,208 |
| Short return visit (20+ min) | 454 | $42,742 | $62 |
| Replacement of knee joint, both sides of knee | 24 | $28,035 | $1,168 |
| Aspiration and/or injection of fluid from large joint | 229 | $19,484 | $51 |
| Return visit (30+ min) | 148 | $15,725 | $95 |
| New patient visit (30+ min) | 171 | $15,351 | $90 |
| Replacement of knee joint on side of knee | 12 | $13,260 | $1,020 |
| Treatment of upper end of broken thigh bone with placement of stabilizing device or prosthetic replacement | 11 | $11,131 | $1,012 |
| Hyaluronan or derivative, euflexxa, for intra-articular injection, per dose | 33 | $10,340 | None |
| X-ray of hip, 1 view | 161 | $6,271 | $29 |
| X-ray of both knees while standing | 151 | $5,885 | $34 |
| X-ray of knee, 1-2 views | 152 | $5,248 | $30 |
| New patient visit (45+ min) | 31 | $4,558 | $147 |
| X-ray of hip, 2-3 views | 75 | $3,510 | $41 |
| Injection, methylprednisolone acetate, 80 mg | 208 | $2,642 | None |
| Mri scan of leg joint without contrast | 14 | $2,388 | $171 |
| Aspiration and/or injection of fluid from medium joint | 46 | $2,217 | $44 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 26 | $1,668 | $64 |
| X-ray of knee, 3 views | 38 | $1,392 | $37 |
| Short return visit | 33 | $1,349 | $39 |
| X-ray of pelvis, 1-2 views | 31 | $943 | $29 |
| Injection, methylprednisolone acetate, 40 mg | 36 | $184 | None |
2016: 22 services
| Replacement of thigh bone and hip joint with prosthesis | 55 | $72,318 | $1,226 |
| Short return visit (20+ min) | 410 | $44,377 | $64 |
| Replacement of knee joint, both sides of knee | 25 | $32,599 | $1,207 |
| Aspiration and/or injection of fluid from large joint | 182 | $17,547 | $51 |
| New patient visit (30+ min) | 169 | $15,649 | $93 |
| Return visit (30+ min) | 149 | $14,849 | $89 |
| X-ray of hip, 1 view | 152 | $5,952 | $28 |
| X-ray of knee, 1-2 views | 154 | $5,873 | $31 |
| X-ray of both knees while standing | 146 | $5,840 | $34 |
| Hyaluronan or derivative, euflexxa, for intra-articular injection, per dose | 18 | $4,287 | None |
| Mri scan of leg joint without contrast | 22 | $4,124 | $179 |
| New patient visit (45+ min) | 28 | $4,031 | $144 |
| Short return visit | 66 | $3,090 | $41 |
| X-ray of hip, 2-3 views | 67 | $3,051 | $41 |
| X-ray of pelvis, 1-2 views | 74 | $2,432 | $27 |
| Injection, methylprednisolone acetate, 80 mg | 176 | $1,887 | None |
| Aspiration and/or injection of fluid from medium joint | 33 | $1,846 | $44 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 14 | $1,703 | $122 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 16 | $1,093 | $64 |
| X-ray of knee, 3 views | 26 | $931 | $36 |
| X-ray of lower and sacral spine, 2-3 views | 19 | $679 | $34 |
| Injection, methylprednisolone acetate, 40 mg | 23 | $93 | None |
2015: 19 services
| Replacement of thigh bone and hip joint with prosthesis | 48 | $60,267 | $1,182 |
| Replacement of knee joint, both sides of knee | 25 | $36,301 | $1,210 |
| Short return visit (20+ min) | 293 | $30,665 | $67 |
| Return visit (30+ min) | 176 | $21,783 | $101 |
| Aspiration and/or injection of fluid from large joint | 155 | $12,228 | $52 |
| New patient visit (30+ min) | 117 | $11,097 | $95 |
| New patient visit (45+ min) | 49 | $7,436 | $152 |
| X-ray of pelvis, 1-2 views | 171 | $7,344 | $26 |
| X-ray of hip on one side of body, 1 view | 131 | $5,454 | $25 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 16 | $2,895 | $181 |
| X-ray of knee, 1-2 views | 81 | $2,849 | $29 |
| X-ray of both knees while standing | 66 | $2,553 | $32 |
| X-ray of knee, 3 views | 68 | $2,523 | $34 |
| Aspiration and/or injection of fluid from medium joint | 24 | $1,337 | $42 |
| Injection, methylprednisolone acetate, 80 mg | 158 | $1,140 | None |
| X-ray of lower and sacral spine, minimum of 4 views | 17 | $894 | $47 |
| Short return visit | 13 | $545 | $42 |
| X-ray of lower and sacral spine, 2-3 views | 12 | $462 | $36 |
| Injection, methylprednisolone acetate, 20 mg | 14 | $39 | None |
2014: 25 services
| Replacement of thigh bone and hip joint with prosthesis | 33 | $36,002 | $1,091 |
| Short return visit (20+ min) | 267 | $24,925 | $64 |
| Replacement of knee joint, both sides of knee | 15 | $18,276 | $1,142 |
| Return visit (30+ min) | 118 | $14,257 | $100 |
| Treatment of upper end of broken thigh bone with placement of stabilizing device or prosthetic replacement | 11 | $11,909 | $1,083 |
| Aspiration and/or injection of fluid from large joint | 127 | $9,036 | $51 |
| Partial removal of spine bone with release of lower spinal cord and/or nerves, 1 segment | 13 | $8,825 | $630 |
| New patient visit (30+ min) | 84 | $7,835 | $93 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 35 | $6,455 | $179 |
| X-ray of pelvis, minimum of 3 views | 72 | $4,158 | $44 |
| New patient visit (45+ min) | 28 | $4,156 | $148 |
| Partial removal of spine bone with release of spinal cord and/or nerves, each additional segment | 15 | $3,931 | $136 |
| X-ray of pelvis, 1-2 views | 99 | $3,225 | $28 |
| X-ray of knee, 3 views | 65 | $2,854 | $38 |
| Ultrasonic guidance for needle placement | 34 | $2,695 | $71 |
| Mri scan of leg joint without contrast | 13 | $2,606 | $186 |
| X-ray of lower and sacral spine, minimum of 4 views | 46 | $2,402 | $48 |
| X-ray of ribs of one side of body, minimum of 2 views | 27 | $1,348 | $41 |
| X-ray of hip on one side of body, 1 view | 38 | $1,296 | $27 |
| X-ray of knee, 1-2 views | 34 | $1,239 | $30 |
| Short return visit | 32 | $1,220 | $36 |
| Aspiration and/or injection of fluid from medium joint | 16 | $888 | $42 |
| X-ray of knee, 4 or more views | 17 | $765 | $45 |
| Injection, methylprednisolone acetate, 80 mg | 128 | $745 | None |
| X-ray of thigh, 2 views | 13 | $584 | $29 |
2013: 20 services
| Replacement of thigh bone and hip joint with prosthesis | 19 | $23,135 | $1,218 |
| Short return visit (20+ min) | 224 | $22,177 | $67 |
| Treatment of broken neck of thigh bone with bone implant | 15 | $15,509 | $1,034 |
| Replacement of knee joint, both sides of knee | 12 | $13,576 | $1,044 |
| Aspiration and/or injection of fluid from large joint | 144 | $11,336 | $54 |
| New patient visit (30+ min) | 115 | $10,847 | $94 |
| Treatment of upper end of broken thigh bone with placement of stabilizing device or prosthetic replacement | 11 | $10,597 | $963 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 47 | $8,425 | $176 |
| Ultrasonic guidance for needle placement | 28 | $6,518 | $217 |
| X-ray of pelvis, 1-2 views | 103 | $4,446 | $29 |
| Return visit (30+ min) | 24 | $2,420 | $97 |
| X-ray of knee, 1-2 views | 53 | $1,968 | $31 |
| X-ray of knee, 3 views | 37 | $1,617 | $39 |
| Short return visit | 42 | $1,577 | $36 |
| X-ray of lower and sacral spine, minimum of 4 views | 26 | $1,348 | $50 |
| Injection, methylprednisolone acetate, 80 mg | 125 | $850 | None |
| X-ray lower and sacral spine, 2-3 views bending views | 18 | $754 | $42 |
| X-ray of hip on one side of body, 1 view | 16 | $537 | $28 |
| X-ray of lower and sacral spine, 2-3 views | 12 | $447 | $37 |
| Injection, methylprednisolone acetate, 40 mg | 14 | $46 | None |
Drugs they prescribed that Part D paid
$4,374
Pharmacies billed $4,374 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 24% of their Part D prescriptions (45 of 190) in 2024. At or below the middle of the specialty; the typical orthopedic surgery clinician is at 31%.
183 generic and fewer than 11 brand-name prescriptions · $4,374 in drug cost · 14 antibiotic prescriptions to 12 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Celecoxib | 25 | $2,249 | $90 |
| Diclofenac | 18 | $309 | $17 |
| Meloxicam | 29 | $230 | $8 |
| Gabapentin | 19 | $108 | $6 |
| Oxycodone | 16 | $97 | $6 |
See all 6 drugs
| Celecoxib | 25 | $2,249 | $90 |
| Diclofenac | 18 | $309 | $17 |
| Meloxicam | 29 | $230 | $8 |
| Gabapentin | 19 | $108 | $6 |
| Oxycodone | 16 | $97 | $6 |
| Tramadol | 18 | $60 | $3 |
Year by year
| 2024 | 190 | 108 | 24% (45) | None | $4,374 |
| 2023 | 232 | 127 | 25% (59) | None | $3,028 |
| 2022 | 329 | 150 | 25% (83) | None | $7,869 |
| 2021 | 276 | 136 | 17% (47) | None | $6,957 |
| 2020 | 404 | 168 | 18% (72) | None | $10,216 |
| 2019 | 645 | 264 | 22% (140) | 5% | $24,860 |
| 2018 | 544 | 234 | 44% (241) | 6% | $22,556 |
| 2017 | 445 | 202 | 39% (172) | 7% | $11,603 |
| 2016 | 583 | 228 | 37% (216) | 11% | $32,490 |
| 2015 | 582 | 224 | 49% (285) | 10% | $16,368 |
| 2014 | 585 | 206 | 53% (308) | 11% | $20,558 |
| 2013 | 528 | 182 | 41% (218) | 18% | $21,537 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 8 drugs
| Celecoxib | 26 | $830 | $32 |
| Gabapentin | 28 | $352 | $13 |
| Meloxicam | 36 | $328 | $9 |
| Tramadol | 28 | $136 | $5 |
| Oxycodone | 16 | $110 | $7 |
| Hydrocodone-Acetaminophen | 12 | $101 | $8 |
| Methylprednisolone | 12 | $92 | $8 |
| Prednisone | 12 | $49 | $4 |
2022: 9 drugs
| Celecoxib | 50 | $3,087 | $62 |
| Lidocaine | 11 | $858 | $78 |
| Diclofenac | 42 | $700 | $17 |
| Hydrocodone-Acetaminophen | 24 | $400 | $17 |
| Oxycodone | 26 | $256 | $10 |
| Meloxicam | 40 | $184 | $5 |
| Tramadol | 30 | $113 | $4 |
| Lorazepam | 12 | $55 | $5 |
| Amoxicillin | 14 | $32 | $2 |
2021: 9 drugs
| Celecoxib | 66 | $4,552 | $69 |
| Diclofenac | 29 | $521 | $18 |
| Meloxicam | 40 | $171 | $4 |
| Oxycodone | 14 | $164 | $12 |
| Cephalexin | 14 | $151 | $11 |
| Hydrocodone-Acetaminophen | 14 | $150 | $11 |
| Ibuprofen | 12 | $78 | $6 |
| Amoxicillin | 17 | $41 | $2 |
| Tramadol | 16 | $39 | $2 |
2020: 8 drugs
| Celecoxib | 63 | $3,330 | $53 |
| Diclofenac | 118 | $3,317 | $28 |
| Hydrocodone-Acetaminophen | 18 | $305 | $17 |
| Meloxicam | 46 | $300 | $7 |
| Oxycodone | 21 | $257 | $12 |
| Tramadol | 30 | $162 | $5 |
| Omeprazole | 18 | $113 | $6 |
| Amoxicillin | 16 | $62 | $4 |
2019: 10 drugs
| Celecoxib | 119 | $7,589 | $64 |
| Diclofenac | 133 | $5,050 | $38 |
| Oxycodone | 46 | $672 | $15 |
| Hydrocodone-Acetaminophen | 42 | $610 | $15 |
| Omeprazole | 55 | $426 | $8 |
| Gabapentin | 22 | $355 | $16 |
| Tramadol | 40 | $232 | $6 |
| Meloxicam | 45 | $229 | $5 |
| Cephalexin | 11 | $138 | $13 |
| Amoxicillin | 25 | $68 | $3 |
2018: 9 drugs
| Celecoxib | 64 | $7,093 | $111 |
| Diclofenac | 76 | $2,059 | $27 |
| Oxycodone | 83 | $1,097 | $13 |
| Hydrocodone-Acetaminophen | 59 | $878 | $15 |
| Oxycodone-Acetaminophen | 13 | $252 | $19 |
| Tramadol | 59 | $239 | $4 |
| Meloxicam | 42 | $219 | $5 |
| Amoxicillin | 33 | $110 | $3 |
| Acetaminophen-Codeine | 11 | $99 | $9 |
2017: 10 drugs
| Celecoxib | 31 | $3,223 | $104 |
| Diclofenac | 73 | $2,284 | $31 |
| Oxycodone | 40 | $652 | $16 |
| Acetaminophen-Codeine | 28 | $336 | $12 |
| Tramadol | 54 | $262 | $5 |
| Hydrocodone-Acetaminophen | 27 | $202 | $7 |
| Oxycodone-Acetaminophen | 11 | $173 | $16 |
| Amoxicillin | 39 | $138 | $4 |
| Ibuprofen | 18 | $132 | $7 |
| Ibu | 13 | $78 | $6 |
2016: 14 drugs
| Diclofenac | 86 | $9,720 | $113 |
| Eliquis | 12 | $4,150 | $346 |
| Celecoxib | 37 | $3,860 | $104 |
| Hydrocodone-Acetaminophen | 63 | $1,421 | $23 |
| Oxycontin | 15 | $961 | $64 |
| Oxycodone | 49 | $844 | $17 |
| Voltaren | 12 | $552 | $46 |
| Oxycodone-Acetaminophen | 21 | $407 | $19 |
| Tramadol | 56 | $395 | $7 |
| Methylprednisolone | 18 | $340 | $19 |
| Amoxicillin | 70 | $248 | $4 |
| Sulfamethoxazole-Trimethoprim | 12 | $190 | $16 |
| Ibuprofen | 18 | $110 | $6 |
| Meloxicam | 17 | $98 | $6 |
2015: 9 drugs
| Celecoxib | 40 | $4,708 | $118 |
| Hydrocodone-Acetaminophen | 108 | $1,886 | $17 |
| Diclofenac | 83 | $1,430 | $17 |
| Oxycodone | 48 | $745 | $16 |
| Tramadol | 86 | $461 | $5 |
| Methylprednisolone | 18 | $304 | $17 |
| Amoxicillin | 55 | $183 | $3 |
| Hydromorphone | 15 | $117 | $8 |
| Gabapentin | 18 | $112 | $6 |
2014: 13 drugs
| Celebrex | 26 | $7,294 | $281 |
| Hydrocodone-Acetaminophen | 133 | $2,357 | $18 |
| Diclofenac | 78 | $1,939 | $25 |
| Voltaren | 14 | $676 | $48 |
| Oxycodone-Acetaminophen | 30 | $657 | $22 |
| Oxycontin | 13 | $579 | $45 |
| Tramadol | 93 | $569 | $6 |
| Oxycodone | 26 | $435 | $17 |
| Methylprednisolone | 14 | $306 | $22 |
| Gabapentin | 24 | $218 | $9 |
| Amoxicillin | 33 | $96 | $3 |
| Clindamycin | 12 | $73 | $6 |
| Diazepam | 14 | $56 | $4 |
2013: 11 drugs
| Celebrex | 42 | $9,869 | $235 |
| Ampicillin | 46 | $2,406 | $52 |
| Diclofenac | 77 | $2,114 | $27 |
| Hydrocodone-Acetaminophen | 99 | $1,493 | $15 |
| Methylprednisolone | 22 | $518 | $24 |
| Tramadol | 51 | $353 | $7 |
| Oxycodone-Acetaminophen | 28 | $282 | $10 |
| Acetaminophen-Codeine | 17 | $143 | $8 |
| Sodium Chloride | 23 | $96 | $4 |
| Diazepam | 13 | $55 | $4 |
| Amoxicillin | 15 | $54 | $4 |
Money from drug and device companies
$78,683 in 2025
| 2025 | 5 | 49 | $75,208 | $78,683 |
| 2024 | 2 | 35 | $61,285 | $63,293 |
| 2023 | 2 | 22 | $27,056 | $29,089 |
| 2022 | 1 | 24 | $42,410 | $45,287 |
| 2021 | 3 | 22 | $31,296 | $32,050 |
| 2020 | 2 | 20 | $40,219 | $41,313 |
| 2019 | 3 | 13 | $2,700 | $10,020 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Medical Device Business Services | Actis | $68,420 | 40 payments
|
| DePuy Synthes Products | Actis | $10,098 | 6 payments
|
| DePuy Synthes Sales | Velys | $92 | 1 payment
|
| Ethicon US | Stratafix | $39 | 1 payment
|
| Pacira Pharmaceuticals | Exparel | $33 | 1 payment
|
See all 49 published payments
| Medical Device Business Services | Consulting · 2025-12-09 | Actis | $6,030 |
| Medical Device Business Services | Consulting · 2025-11-03 | Actis | $670 |
| Medical Device Business Services | Consulting · 2025-11-03 | Actis | $1,005 |
| Medical Device Business Services | Consulting · 2025-11-03 | Actis | $1,005 |
| Medical Device Business Services | Consulting · 2025-11-03 | Actis | $168 |
| Medical Device Business Services | Consulting · 2025-11-03 | Actis | $1,340 |
| DePuy Synthes Products | Consulting · 2025-10-22 | Actis | $9,380 |
| DePuy Synthes Products | Travel · 2025-10-22 | Actis | $43 |
| Medical Device Business Services | Consulting · 2025-10-20 | Actis | $9,380 |
| Medical Device Business Services | Travel · 2025-10-20 | Actis | $43 |
| DePuy Synthes Products | Travel · 2025-10-10 | Velys | $156 |
| DePuy Synthes Products | Travel · 2025-10-10 | Velys | $156 |
| Medical Device Business Services | Consulting · 2025-10-09 | Actis | $4,355 |
| Medical Device Business Services | Consulting · 2025-10-07 | Actis | $4,355 |
| Medical Device Business Services | Travel · 2025-09-29 | Actis | $43 |
| Medical Device Business Services | Consulting · 2025-09-29 | Actis | $5,360 |
| Medical Device Business Services | Meals · 2025-09-26 | None | $68 |
| Medical Device Business Services | Meals · 2025-09-26 | None | $49 |
| Medical Device Business Services | Meals · 2025-09-26 | None | $48 |
| Medical Device Business Services | Travel · 2025-09-25 | None | $272 |
| Medical Device Business Services | Consulting · 2025-09-17 | Actis | $10,720 |
| DePuy Synthes Products | Travel · 2025-09-17 | Velys | $180 |
| DePuy Synthes Products | Travel · 2025-09-17 | Velys | $182 |
| Medical Device Business Services | Travel · 2025-09-10 | None | $328 |
| Medical Device Business Services | Meals · 2025-09-10 | None | $23 |
| Medical Device Business Services | Meals · 2025-09-10 | None | $27 |
| Medical Device Business Services | Travel · 2025-09-09 | None | $301 |
| Medical Device Business Services | Meals · 2025-09-08 | Inhance | $108 |
| Medical Device Business Services | Travel · 2025-08-26 | None | $158 |
| Medical Device Business Services | Travel · 2025-08-26 | None | $50 |
| Medical Device Business Services | Travel · 2025-08-26 | None | $311 |
| Medical Device Business Services | Travel · 2025-08-26 | None | $50 |
| Medical Device Business Services | Travel · 2025-08-25 | None | $6 |
| Medical Device Business Services | Travel · 2025-08-20 | None | $6 |
| Medical Device Business Services | Consulting · 2025-07-16 | Actis | $4,355 |
| Medical Device Business Services | Consulting · 2025-06-27 | Actis | $1,005 |
| Medical Device Business Services | Consulting · 2025-06-26 | Actis | $1,340 |
| Medical Device Business Services | Consulting · 2025-06-09 | Actis | $9,045 |
| Medical Device Business Services | Consulting · 2025-06-03 | Actis | $4,355 |
| Ethicon US | Meals · 2025-05-31 | Stratafix | $39 |
| Medical Device Business Services | Meals · 2025-05-31 | Velys | $34 |
| Medical Device Business Services | Meals · 2025-05-31 | Velys | $17 |
| Medical Device Business Services | Travel · 2025-05-30 | Velys | $292 |
| Medical Device Business Services | Meals · 2025-05-30 | Velys | $72 |
| Medical Device Business Services | Travel · 2025-05-30 | Velys | $206 |
| Medical Device Business Services | Consulting · 2025-04-07 | Actis | $1,340 |
| Medical Device Business Services | Meals · 2025-03-27 | None | $81 |
| DePuy Synthes Sales | Meals · 2025-02-12 | Velys | $92 |
| Pacira Pharmaceuticals | Meals · 2025-02-07 | Exparel | $33 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $63,293
| Medical Device Business Services | Actis | $63,178 | 34 payments
|
| DePuy Synthes Sales | None | $115 | 1 payment
|
2023: $29,089
| Medical Device Business Services | Actis | $28,805 | 20 payments
|
| DePuy Synthes Sales | Velys | $284 | 2 payments
|
2022: $45,287
| Medical Device Business Services | Actis | $45,287 | 24 payments
|
2021: $32,050
| Medical Device Business Services | Actis | $31,382 | 15 payments
|
| DePuy Synthes Sales | Spine & Trauma 3d Navigation | $630 | 5 payments
|
| Heron Therapeutics | Zynrelef | $38 | 2 payments
|
2020: $41,313
| Medical Device Business Services | Actis | $41,297 | 19 payments
|
| DePuy Synthes Sales | Attune | $16 | 1 payment
|
2019: $10,020
| Medical Device Business Services | Actis | $5,781 | 9 payments
|
| Pacira Pharmaceuticals | Exparel | $4,134 | 3 payments
|
| DePuy Synthes Sales | None | $105 | 1 payment
|
Checkups this office reported
1 measures · 2023
Medicare asked this office to report how often certain checkups happened in 2023. This is not a grade for the doctor. A specialist’s patients may not need every screening.
- Medicare’s overall office score
- 100.0 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
| Risk-standardized complication rate (RSCR) following elective primary total hip arthroplasty (THA) and/or total knee arthroplasty (TKA) for Merit-based Incentive Payment System (MIPS)As Medicare defines this measure | 0% | None |
Professional record
- NPI
- 1174710545
- Licence
- CA A98952California A98952: Current · expires 2028-04-30
- Group
- California Pacific Orthopaedics and Sports Medicine A Medical Corporat · Regents of the University of California - UCSF
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- Yes
- Taxonomy
- Orthopedic surgery (207X00000X)
- Mailing address
- 300 Pasteur Dr Rm R144, Stanford Orthopaedic Surgery, Stanford, CA, 94305
- NPI first listed
- 2007-10-01
- NPI last updated
- 2007-10-01
This is when the NPI record was last certified, not a medical board exam.